Analysts Set Sotera Health Company (NASDAQ:SHC) Target Price at $17.80

Shares of Sotera Health Company (NASDAQ:SHC) have received an average rating of “Moderate Buy” from the seven ratings firms that are presently covering the stock, MarketBeat reports. Three analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $17.80.

A number of equities research analysts have recently weighed in on SHC shares. JPMorgan Chase & Co. lifted their target price on shares of Sotera Health from $14.00 to $16.00 and gave the company a “neutral” rating in a research note on Wednesday, November 5th. BMO Capital Markets assumed coverage on Sotera Health in a research report on Thursday, November 13th. They set an “outperform” rating and a $19.00 price objective on the stock. William Blair assumed coverage on Sotera Health in a research report on Thursday, December 18th. They issued an “outperform” rating for the company. Weiss Ratings restated a “hold (c-)” rating on shares of Sotera Health in a research note on Monday, December 22nd. Finally, Piper Sandler lifted their price target on Sotera Health from $15.00 to $17.00 and gave the company a “neutral” rating in a research report on Wednesday, November 5th.

Sotera Health Stock Performance

NASDAQ SHC opened at $17.70 on Wednesday. The stock has a market cap of $5.03 billion, a P/E ratio of 93.16 and a beta of 1.81. Sotera Health has a fifty-two week low of $9.53 and a fifty-two week high of $17.83. The stock has a 50 day simple moving average of $16.65 and a two-hundred day simple moving average of $14.88. The company has a debt-to-equity ratio of 4.04, a quick ratio of 2.18 and a current ratio of 2.38.

Sotera Health (NASDAQ:SHC) last announced its earnings results on Tuesday, November 4th. The company reported $0.26 EPS for the quarter, beating analysts’ consensus estimates of $0.22 by $0.04. The company had revenue of $311.31 million during the quarter, compared to the consensus estimate of $303.63 million. Sotera Health had a return on equity of 43.69% and a net margin of 4.82%.Sotera Health has set its FY 2025 guidance at 0.810-0.860 EPS. On average, analysts forecast that Sotera Health will post 0.61 earnings per share for the current year.

Insider Activity

In other news, CEO Michael B. Jr. Petras sold 434,104 shares of the company’s stock in a transaction dated Monday, December 8th. The shares were sold at an average price of $16.45, for a total value of $7,141,010.80. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Gtcr Investment Xi Llc sold 6,480,000 shares of the stock in a transaction dated Wednesday, December 3rd. The stock was sold at an average price of $16.33, for a total transaction of $105,818,400.00. Following the completion of the transaction, the director owned 22,735,301 shares of the company’s stock, valued at approximately $371,267,465.33. The trade was a 22.18% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 29,384,104 shares of company stock worth $471,824,511. Corporate insiders own 55.12% of the company’s stock.

Hedge Funds Weigh In On Sotera Health

Several large investors have recently made changes to their positions in SHC. TPG GP A LLC bought a new stake in shares of Sotera Health in the 1st quarter worth approximately $79,126,000. Sculptor Capital LP boosted its holdings in Sotera Health by 80.8% in the first quarter. Sculptor Capital LP now owns 9,037,511 shares of the company’s stock worth $105,377,000 after acquiring an additional 4,037,511 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of Sotera Health by 10.5% in the third quarter. Vanguard Group Inc. now owns 16,471,792 shares of the company’s stock worth $259,101,000 after acquiring an additional 1,561,282 shares during the last quarter. Voss Capital LP grew its stake in shares of Sotera Health by 146.7% in the third quarter. Voss Capital LP now owns 1,850,000 shares of the company’s stock worth $29,100,000 after acquiring an additional 1,100,000 shares during the last quarter. Finally, Norges Bank bought a new position in shares of Sotera Health during the second quarter valued at $9,607,000. 91.03% of the stock is currently owned by hedge funds and other institutional investors.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.